FEDERAL1092d left

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

National Institutes of Health

Posted Oct 14, 2026

Deadline
Oct 11, 2029
1092 days remaining
Amount
Varies
Status
Open
Geographic Scope
National

Description

This Notice of Funding Opportunity (NOFO) invites applications that investigate the etiology of sporadic non-hereditary early-onset cancers (EOCs: ages 18 to 49 years) and the underlying biological mechanisms that play a role in these cancers to inform prevention and control strategies. The proposed research is expected to advance the understanding of the unexplained rise of cancers in young adults. More specifically, studies should focus on one or more of the following: i) identifying what environmental or lifestyle exposures are driving the increase in the incidence of non-hereditary EOCs, and how these factors vary by patient demographics; ii) examining the biological mechanisms and host responses that underlie the increase in EOCs; and iii) identifying how those at increased risk of developing EOCs can be identified more effectively.

In an effort to streamline the application process and sustain momentum in this critical research area, this NOFO supports both exploratory/developmental and standard research projects through a grant award instrument.

Funding Details

Key Dates

Posted: Oct 14, 2026Deadline: Oct 11, 2029

Quick Facts

CFDA Number
93.113
Funder Type
Federal Agency
Grant Level
FEDERAL
Last Verified
Oct 14, 2026

Geographic Scope

national

ReferenceGL-91497C

91497cad-f2c5-43e0-9415-4091c72e0f5d

Intelligence

Ready to apply?

Visit the funder's website to start your application.

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional) | GrantLens